Finally, because the effects of anti-CRD4 MR scFv #G11 on macrophage phenotype were more pronounced in the absence of tumor cells (Fig. 5B–K, condition 2), CD206 engagement by soluble mesothelin may compete with anti-CRD4-MR scFv binding. The gene discussed is MSLN; the disease is neoplasm.